TNFA (tnfpharma.com) Bathi resik

TNF Pharmaceuticals generates revenue from licensing unique anti-inflammatory formulas, with business success driven by the outcomes of clinical trials for targeted drugs. This GURU.Markets terminal chart displays the company's profit, where the indicator value is -0.01. Strategic partnerships with biotech laboratories specializing in inflammation create synergy, significantly enhancing the issuer's investment attractiveness for M&A transactions.

TNFA (tnfpharma.com) riwayat Bathi resik perusahaan saka 25.07.2024 nganti 25.09.2025

Rincian metrik keuangan lan pasar tnfpharma.com (TNFA)

- rega lan prakiraan konsensus rega:

Kutipan saham TNF Pharmaceuticals, Inc.|TNFA - Prakiraan konsensus analis

- indikator valuasi pasar bisnis:

Kapitalisasi pasar TNF Pharmaceuticals, Inc.|TNFA - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Akuntansi Saham TNF Pharmaceuticals|TNFA - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku tnfpharma.com|TNFA - Gunggung Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Utang Agregat marang Modal TNF Pharmaceuticals|TNFA - Utang jangka dawa marang modal|Rasio tanggungan utang jangka cendhak marang modal TNF Pharmaceuticals, Inc.|TNFA - Gunggung utang perusahaan|Utang-utang marang nilai buku TNF Pharmaceuticals, Inc.|TNFA - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan TNF Pharmaceuticals|Rasio likuiditas perantara tnfpharma.com

- indikator pendapatan resik lan kelipatan nilai:

TNFA - Bathi resik perusahaan

Pambiji fundamental:TNFA TNF Pharma

This indicator reflects daily net profit dynamics, allowing investors to track real-time business efficiency without quarterly lags. For TNF Pharmaceuticals (TNFA), the company's book profit demonstrates how the implementation of eco-friendly closed-loop production and ESG standards impacts financial stability, transforming technological modernization into a long-term driver of asset value growth.

Pesaing utama